Waiting for FDA to Catch Up: What Hospitals Can Do to Address Supply Chain and Device Shortages
Peter Urbanowicz, managing director and co-head of Alvarez and Marsal’s Healthcare Industry Group, discusses the FDA’s new focus in addressing supply chain and device shortages posed by the COVID-19 pandemic and what hospitals should be doing in the meantime to adjust.
On this week's episode of Data Book, Chief Healthcare Executive™ spoke with Peter Urbanowicz, managing director and co-head of Alvarez and Marsal’s Healthcare Industry Group. We discussed the FDA’s recent shift in priorities to address supply chain issues, device shortages, and the backlog of drug approvals as well as how technology can help. We also talked about how hospitals are handling these issues and what they can do as they wait for the FDA to catch up.
As hospitals face cost pressures, concerns emerge over cuts in infection control
June 5th 2025The Association for Professionals in Infection Control and Epidemiology is hearing reports of layoffs in those programs. Leaders of the association and the Leapfrog Group warn about risks to patients.
